Dauntless Investment Group, LLC 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-03 1:51 pm Purchase |
2025-02-26 | 13G | AEON Biopharma, Inc. AEON |
Dauntless Investment Group, LLC | 108,224 9.700% |
108,224 (New Position) |
Filing |